ReviewTargeted oncology2019

Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current State.

Petros Grivas et al.PubMed ↗Publisher ↗

No numbers read from the abstract.